Following the Food and Drug Administration’s approval of Lutathera and Pluvicto in 2018 and 2022, respectively, we predicted ...
Cancer therapy has advanced with molecularly targeted approaches and immunotherapy, yet chemotherapy remains essential for ...
The Chinese Society of Nuclear Medicine conducted a national nuclear medicine survey in January 2024. The purpose of the survey was to update the data from 2019 and provide a scientific basis for ...
Journal of Nuclear Medicine February 2025, jnumed.124.268835; DOI: https://doi.org/10.2967/jnumed.124.268835 ...
Journal of Nuclear Medicine February 2025, jnumed.124.268079; DOI: https://doi.org/10.2967/jnumed.124.268079 ...
SPECT Deserves RESPECT: The Potential of SPECT/CT to Optimize Patient Outcomes with Theranostics Therapy ...
Journal of Nuclear Medicine February 2025, jnumed.124.268818; DOI: https://doi.org/10.2967/jnumed.124.268818 ...
Journal of Nuclear Medicine February 2025, jnumed.124.268586; DOI: https://doi.org/10.2967/jnumed.124.268586 ...
Journal of Nuclear Medicine February 2025, jnumed.124.268640; DOI: https://doi.org/10.2967/jnumed.124.268640 ...
Journal of Nuclear Medicine February 2025, jnumed.124.268496; DOI: https://doi.org/10.2967/jnumed.124.268496 This paper aims to develop and evaluate the potential of ...
The charity Children’s Cancer Research Fund (https://www.childrenscancerresearchfund.co.uk/) convened a symposium in Manchester, U.K., in September 2024. Twenty-one invited speakers included pediatric ...